[Histonet] MAP-2 antibody

Lott, Robert Robert.Lott <@t> trinitymedicalonline.com
Fri May 29 11:35:16 CDT 2009


Hi Everyone,

One of our pathologists is interested in MAP-2 IHC for the following
application:

 

Microtubule Associated Protein-2 Is a Sensitive Marker of Primary and
Metastatic Neuroblastoma.                         

Krishnan C, Heerema-McKenney A, Arber DA.  Department of Pathology,
Stanford University, Stanford, CA.

 

Comment: Microtubule associated protein-2 (MAP-2) is a protein expressed
in high levels in cells derived from the neural crest.  

It is a very robust marker of neuronal differentiation and has been used
most often in evaluating neuronal differentiation in tumors 

of the central nervous system.  MAP-2 showed comparable sensitivity in
staining primary neuroblastomas 

(pre- and post-treatment samples) as compared to synaptophysin,
chromogranin, CD56, and beta-catenin.  

In contrast to other markers of neuroblastoma, MAP-2 did not show
significant cross reactivity to native bone marrow 

precursors, thus eliminating a potential source of confusion.

 

Does anyone use this antibody for this or like applications....

I have looked and am "fairly" sure that there is not an IVD available,
but would still be interested in knowing which antibody you use.

 

Thanks,

 

Robert L. Lott, HTL(ASCP) / Manager, Anatomic Pathology 

Trinity Medical Center/ LabFirst/ 800 Montclair Road / Birmingham, AL
35213/ 205-592-5387 

 



--------------------------------------------------------------------------
Disclaimer: This electronic message may contain information that is
Proprietary, Confidential, or legally privileged or protected. It
is intended only for the use of the individual(s) and entity named
in the message. If you are not an intended recipient of this
message, please notify the sender immediately and delete the
material from your computer. Do not deliver, distribute or copy
this message and do not disclose its contents or take any action in
reliance on the information it contains.


More information about the Histonet mailing list